Major Adverse Cardiovascular Events
Major Adverse Cardiovascular Events - Related Videos
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
0 Views •
Cited by 31 •
2015
Here we outline the procedure for MRI-guided repetitive transcranial magnetic stimulation to the dorsomedial prefrontal cortex as an experimental treatment for major depressive disorder.
08:08
Major Components of the Light Microscope
0 Views •
2008
The light microscope is a basic tool for the cell biologist, who should have a thorough understanding of how it works, how it should be aligned for different applications, and how it should be maintained as required to obtain maximum image-forming capacity and resolution. The components of the microscope are described in detail here.
12:37
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
0 Views •
Cited by 16 •
2016
Here we present a protocol to assess cardiopulmonary function in awake swine, at rest and during graded treadmill exercise. Chronic instrumentation allows for repeated hemodynamic measurements uninfluenced by cardiodepressive anesthetic agents.
01:12
Local Anesthetics: Adverse Effects
0 Views •
2023
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects. Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
01:27
Major Hormones and Their Functions
0 Views •
2024
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon. Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
FAQs
Atherosclerotic plaque disruption can expose material that promotes thrombosis, or clot formation. The resulting clot may reduce blood flow to the heart or brain, creating conditions associated with myocardial infarction, stroke, or cardiovascular death. This mechanism explains why MACE reflects clinically consequential vascular disease rather than an isolated change in a laboratory measurement.
MACE is a composite endpoint, so investigators determine which serious cardiovascular outcomes to combine for a particular study. Although cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke are commonly included, the exact grouping can vary. Comparing results therefore requires attention to the study’s stated endpoint definition, not just the MACE label.
MACE records consequential clinical outcomes, whereas an intermediate measure may reflect a laboratory value or physiological change without showing whether a serious event occurred. An intervention can improve an intermediate measure yet have a different effect on patient outcomes. MACE helps trials evaluate whether treatment or prevention strategies influence events that matter directly to cardiovascular health.
Investigators specify the composite outcome, follow participants for the study period, and compare the occurrence of included events between treatment groups or strategies. The resulting comparison helps assess whether an intervention reduces serious cardiovascular outcomes. Because the endpoint combines several events, interpretation should remain tied to the individual components and the definition used in that trial.
Preventive strategies are assessed not only by changes in risk markers or physiological measures but also by whether fewer consequential cardiovascular events occur. Tracking MACE provides a clinically oriented outcome for comparing such approaches. It can show whether prevention is associated with reduced cardiovascular death, myocardial infarction, or stroke within the study’s specified composite definition.
MACE can help estimate cardiovascular risk by summarizing the occurrence of serious outcomes within a defined patient population or clinical study. Its value depends on the events included and how consistently they are assessed. In medicine, this outcome-oriented information complements intermediate measurements and supports evaluation of the likelihood of consequential cardiovascular disease.